589 related articles for article (PubMed ID: 33632214)
1. G-quadruplexes: a promising target for cancer therapy.
Kosiol N; Juranek S; Brossart P; Heine A; Paeschke K
Mol Cancer; 2021 Feb; 20(1):40. PubMed ID: 33632214
[TBL] [Abstract][Full Text] [Related]
2. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
[TBL] [Abstract][Full Text] [Related]
3. EMICORON: A multi-targeting G4 ligand with a promising preclinical profile.
Porru M; Zizza P; Franceschin M; Leonetti C; Biroccio A
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1362-1370. PubMed ID: 27838395
[TBL] [Abstract][Full Text] [Related]
4. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
5. G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting.
Romano F; Di Porzio A; Iaccarino N; Riccardi G; Di Lorenzo R; Laneri S; Pagano B; Amato J; Randazzo A
Expert Opin Ther Pat; 2023 Nov; 33(11):745-773. PubMed ID: 37855085
[TBL] [Abstract][Full Text] [Related]
6. Crossroads of telomere biology and anticancer drug discovery.
Seimiya H
Cancer Sci; 2020 Sep; 111(9):3089-3099. PubMed ID: 32579791
[TBL] [Abstract][Full Text] [Related]
7. Oncogene Expression Modulation in Cancer Cell Lines by DNA G-Quadruplex-Interactive Small Molecules.
Francisco AP; Paulo A
Curr Med Chem; 2017; 24(42):4873-4904. PubMed ID: 27573064
[TBL] [Abstract][Full Text] [Related]
8. Critical role of hnRNP A1 in activating KRAS transcription in pancreatic cancer cells: A molecular mechanism involving G4 DNA.
Cogoi S; Rapozzi V; Cauci S; Xodo LE
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1389-1398. PubMed ID: 27888145
[TBL] [Abstract][Full Text] [Related]
9. G-quadruplex in cancer biology and drug discovery.
Nakanishi C; Seimiya H
Biochem Biophys Res Commun; 2020 Oct; 531(1):45-50. PubMed ID: 32312519
[TBL] [Abstract][Full Text] [Related]
10. Promise of G-Quadruplex Structure Binding Ligands as Epigenetic Modifiers with Anti-Cancer Effects.
Sengupta A; Ganguly A; Chowdhury S
Molecules; 2019 Feb; 24(3):. PubMed ID: 30736345
[TBL] [Abstract][Full Text] [Related]
11. G-Quadruplexes: Emerging Targets for the Structure-Based Design of Potential Anti-Cancer and Antiviral Therapies.
Mitrasinovic PM
Acta Chim Slov; 2020 Sep; 67(3):683-700. PubMed ID: 33533427
[TBL] [Abstract][Full Text] [Related]
12. The Relevance of G-Quadruplexes for DNA Repair.
Linke R; Limmer M; Juranek SA; Heine A; Paeschke K
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830478
[TBL] [Abstract][Full Text] [Related]
13. Ligands stimulating antitumour immunity as the next G-quadruplex challenge.
Miglietta G; Marinello J; Russo M; Capranico G
Mol Cancer; 2022 Sep; 21(1):180. PubMed ID: 36114513
[TBL] [Abstract][Full Text] [Related]
14. Targeting G-Quadruplex DNA for Cancer Chemotherapy.
Debbarma S; Acharya PC
Curr Drug Discov Technol; 2022; 19(3):e140222201110. PubMed ID: 35156574
[TBL] [Abstract][Full Text] [Related]
15. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
[TBL] [Abstract][Full Text] [Related]
16. Targeting multiple G-quadruplex-forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives.
Catalano R; Moraca F; Amato J; Cristofari C; Rigo R; Via LD; Rocca R; Lupia A; Maruca A; Costa G; Catalanotti B; Artese A; Pagano B; Randazzo A; Sissi C; Novellino E; Alcaro S
Eur J Med Chem; 2019 Nov; 182():111627. PubMed ID: 31446246
[TBL] [Abstract][Full Text] [Related]
17. Dimeric aryl-substituted imidazoles may inhibit ALT cancer by targeting the multimeric G-quadruplex in telomere.
Hu MH; Lin XT; Liu B; Tan JH
Eur J Med Chem; 2020 Jan; 186():111891. PubMed ID: 31759730
[TBL] [Abstract][Full Text] [Related]
18. Metal-Organic Compounds as Anticancer Agents: Versatile Building Blocks for Selective Action on G-quadruplexes.
Toro PM; Saldias M; Valenzuela-Barra G
Curr Med Chem; 2023; 30(5):573-600. PubMed ID: 35670351
[TBL] [Abstract][Full Text] [Related]
19. G-quadruplex ligands in cancer therapy: Progress, challenges, and clinical perspectives.
Figueiredo J; Mergny JL; Cruz C
Life Sci; 2024 Mar; 340():122481. PubMed ID: 38301873
[TBL] [Abstract][Full Text] [Related]
20. Discovery of the first dual G-triplex/G-quadruplex stabilizing compound: a new opportunity in the targeting of G-rich DNA structures?
Amato J; Pagano A; Cosconati S; Amendola G; Fotticchia I; Iaccarino N; Marinello J; De Magis A; Capranico G; Novellino E; Pagano B; Randazzo A
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1271-1280. PubMed ID: 27836755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
